maintains vitamin E in the reduced state.13 15 Vitamin E, the most effective chain-breaking membrane-associated antioxidant, competes for peroxyl radicals at a faster rate than polyunsaturated fatty acids, protecting polyunsaturated fatty acids against oxidation."116
An association of these nutrient antioxidants with disease prevention has been observed in epidemiologic studies. 7 
MATERIALS AND METHODS

Subjects
Twelve current smokers were recruited from staff and patients at the Tucson Veterans Affairs Medical Center. One subject prematurely discontinued the study and another was excluded because he was already taking vitamin supplements. Thus, ten smokers completed the study. None had active illnesses or had taken vitamin supplements for at least 2 months prior to enrollment. Three nonsmoking control subjects were also included. All subjects gave written informed consent prior to participation in the study.
Protocol
After an open screw top housing a Teflon septum. The tube and its contents were heated for 3 min at 250°C to hberate the adsorbed hydrocarbons. Five milliliters of the headspace gas was removed in a calibrated precision sampling syringe and injected into a gas chromatograph (Hewlett-Packard 5890; Palo Alto, Calif), containing a 2-m glass column packed vith Carbosphere 60/80 (Alltech; Deerfield, Ill) maintained isothermal at 220°C. The ethane retention time was 4.74 min. The ethane content of the hydrocarbon-free inspirate was also determined daily and was subtracted from the raw ethane measurements of the subjects. The final breath ethane output levels wvere expressed as pmoles.min-lkg-1. Plasma beta carotene and vitamin E levels were measured by photodiode array detector monitoring of high-pressure liquid chromatography effluent, which has previously been detailed by Peng and Although there was an expected linear relationship between age and pack-years (r=0.696, p<0.05), we found no correlation between age and ethane production in smokers (r=0.451, p=NS). The influence of smoking history (measured in packs per day or packyears) on exhaled ethane was also assessed (Fig 1) . Although there was no correlation between the baseline exhaled ethane and packs per day (r=0.318, p=NS), there was a significant correlation between the postantioxidant levels ofethane and packs per day (r=0.671, p<0.05). Similarly, pack-years were not correlatedwith preantioxidant ethane levels (r=0.557, p=NS), but were correlated with postantioxidant ethane levels (r=0.756, p<0.02).
Ethane and Lung Function
No correlation was found between absolute values for FEV1 and ethane, either before or after vitamin supplementation. However, there was a strong inverse correlation between antioxidant-induced decreases in exhaled ethane and FEV1 (percent predicted) in smokers (r=0.926, p<0.001) (Fig 2) . DISCUSSION Petruzzelli and colleagues31 have demonstrated higher levels of thiobarbitiu-ic acid-reactive substances in lung parenchyma from smokers vs nonsmokers, indicating pulmonary lipid peroxidation. Others have identified elevated thiobarbituric acid-reactive substances in the plasma and serum of smokers.32 Our previous observation that smokers exhale more ethane than nonsmokers was confirmed in this study, suggesting that peroxidation induced by smoking can be measured noninvasively.28 Other investigators have recently reported similar findings, eg, Schwarz and colleagues33 found increased ethane production in smoking than in nonsmoking pregnant women. The present study supports the contention that nutritent antioxidants attenuate this peroxidation, although 3 weeks of supplementation was not sufficient to decrease ethane production to the level of nonsmokers.
Being a pilot investigation, the small sample size A Ethane (pm/min/kg) FIGURE 2. Relationship between the change in ethane after 3 veeks vitamin supplementation and the FEV1 (percent predicted).
poses limitations to our study, which will be the subject of future trials. All three nutrients were given, wlhich may not be necessary. Their lack of toxicity, and availability in a single, combined capsule form for convenient dosing, led us to the dose schedule used herein. Larger follow-up trials, using double-blind, placebo-controlled, crossover designs are planned to confirm these findings and assess whether single agents are as active as combinations. It is disputed whether ethane or pentane more accurately indicates lipid peroxidation in vivo. Breath ethane is derived from the peroxidation of c-3 fatty acids, while the peroxidation of w-6 fatty acids produces pentane, which can also be measured in exhalate. However, ethane and pentane appear to behave differently under different conditions. 4 Notably, isoprene may comigrate with pentane on some packed columns, making changes in pentane difficult to assess.35 For this reason, and because ethane is metabolized by the liver more slowly and has lower solubility coefficients in tissues than pentane, we chose ethane as a marker for lipid peroxidation in our studies.
Cigarette smokers have been shown in several studies to have reduced plasma levels of beta carotene,24'36 vitamin E36 and vitamin C,24,25'36 and lung lining fluid levels of vitamin E,27 possibly because of increased utilization of these antioxidants in neutralizing smoking-induced free radicals.25 Supplementation may elevate these antioxidants to levels that more successfully attenuate the increased oxidative insult. The range of baseline plasma vitamin E in our study (0.62 to 1.37 mg/dL) is comparable to other published values (0.5 to 1.6 mg/dL).16 Our baseline beta carotene range (10 to 183 ng/mL) is also comparable to published ranges for smokers in some recent work.3637 Plasma levels of beta carotene in the literature vary widely because of differences in diet and the proportions of smokers in each study. If "normal" levels are defined as 100 ng/mL or greater,37 we found that 4 of our patients had subnormal plasma values: in another recent study, 62% of smokers had subnormal baseline beta carotene levels. 37 When smokers were analyzed individually for changes in exhaled ethane after antioxidant supplementation, there was a significant reduction in eight of ten subjects. In the remaining two, one had a definite increase, while the other showed little change. In a well designed placebo-controlled study of 4 weeks of beta carotene supplementation by Allard and colleagues,38
there was a significant decrease in mean pentane, but a nonsignificant decrease in mean ethane (from 12.9 to 10.4 pmol.kg-1min-1) in smokers. However, there are important differences between our study and theirs. First, we gave vitamin C and vitamin E along with beta carotene. Princen and colleagues39 found that vitamin E protected low-density lipoprotein polyunsaturated fatty acids from cigarette smoke-induced oxidation, while beta carotene did not. Therefore, vitamin E, C, or an additive effect of combined antioxidants may more effectively decrease peroxidation than beta carotene alone. Second, our absolute ethane levels are much lower than those measured by Allard and colleagues.38 Although the precise reason(s) for this is not clear, one possibility is that we routinely measure and subtract ethane levels in the "hydrocarbon-free" inspirate (which in our experience can vary considerably among different lots) from the total levels obtained from the patient. In fact, the absolute decrease of mean ethane in our study, 1.16pmol.kg-min-, is similar to the decrease of2.5 pmol.kg-1min-observed by Allard et The correlation between ethane production and pack-years deserves comment. Even if exhaled ethane reflects a balance between the degree ofinflammatory insult (eg, cigarette smoking) and the levels of endogenous antioxidants, we did not expect to be able to demonstrate a relationship in our small study. Because ethane represents an acute "point in time" indicator of ongoing inflammation, it is possible that pack-years serves as a surrogate marker for current tobacco use. In fact, we did find a correlation between pack-years and packs per day: a much larger study will be necessary to allow adjustment for confounding by these related variables. We hypothesize that the correlation between pack-years smoked and exhaled ethane was present only for postsupplementation ethane and tobacco use because supplementation may have "leveled the playing field." Specifically, by providing exogenous vitamins, we may have minimized the effect of interindividual variability in antioxidant potential, allowing a dose-dependent effect of the insult (tobacco use) to become apparent.
Finally, we also noted a very strong inverse relationship between the change in ethane over the 3-week trial and the FEV1. It is conceivable that individuals with a preserved FEV1 more easily assimilate higher lung levels ofmicronutrient antioxidants, which in turn leads to decreased ethane production. To our knowledge, this issue has never been examined. Conversely, the ability to rapidly correct smoking-induced lung lipid peroxidation (ie, to decrease ethane production) may explain the preserved FEV1. A larger trial examining this relationship should include other measures of free radical activity, eg, conjugated diene levels in lung tissue or lavage, and more objective measures of tobacco consumption.
In conclusion, our study has shown that elevated exhaled ethane in smokers can be reduced by 3 weeks of micronutrient antioxidant supplementation. Although not a substitute for smoking cessation, these agents may attenuate smoking-related lung injury in some individuals. Additional studies are warranted to further investigate these relationships.
